(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The Cystic Fibrosis Center, part of the Division of Pulmonary Medicine, is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty and staff.
Raouf S. Amin, MD Director, Division of Pulmonary Medicine 513-636-6771 email@example.com
Director, Division of Pulmonary Medicine
The Hubert and Dorothy Campbell Chair of Pediatric Pulmonology
Professor, UC Department of Pediatrics
Chronic respiratory failure; sleep disorders in children
Raouf S. Amin, MD, is the director of the Division of Pulmonary Medicine at Cincinnati Children's Hospital Medical Center and a professor for the UC Department of Pediatrics. He graduated from the University of Ain Shams in Cairo Egypt in 1977. Dr. Amin received clinical training in the United Kingdom and the United States. He completed a pulmonary fellowship at Cincinnati Children's Hospital Medical Center in 1993. His research focus is on cardiovascular morbidity of sleep disordered breathing in children. He has several funded protocols from the National Institute of Health.
MD: Aim Shams University, Cairo Egypt, 1978.
Residency: Pediatrics; Michigan State University, Flint, MI.
Certification: Pediatrics 1990; Pediatric Pulmonary Medicine 1994; Sleep Medicine, 1995.
Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, Ballmann M, Boyle MP, Bronsveld I, Campbell PW, Deboeck K, Donaldson SH, Dorkin HL, Dunitz JM, Durie PR, Jain M, Leonard A, McCoy KS, Moss RB, Pilewski JM, Rosenbluth DB, Rubenstein RC, Schechter MS, Botfield M, Ordoñez CL, Spencer-Green GT, Vernillet L, Wisseh S, Yen K, Konstan MW. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax. 2012 Jan;67(1):12-8.
Sung V, Beebe DW, Vandyke R, Fenchel MC, Crimmins NA, Kirk S, Hiscock H, Amin R, Wake M. Does sleep duration predict metabolic risk in obese adolescents attending tertiary services? A cross-sectional study. Sleep. 2011 Jul 1;34(7):891-8.
Sawnani H, Murugappan S, Gutmark E, Donnelly LF, Amin R, Mylavarapu G, Mihaescu M, Khosla S, Kalra M. Influence of gender on pharyngeal airway length in obese adolescents. Ann Otol Rhinol Laryngol. 2010 Dec;119(12):842-7.
Beebe DW, Ris MD, Kramer ME, Long E, Amin R. The association between sleep disordered breathing, academic grades, and cognitive and behavioral functioning among overweight subjects during middle to late childhood. Sleep. 2010 Nov 1;33(11):1447-56.
Beebe DW, Rose D, Amin R. Attention, learning, and arousal of experimentally sleep-restricted adolescents in a simulated classroom. J Adolesc Health. 2010 Nov;47(5):523-5.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35.
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58.
Ednick M, Tinkle BT, Phromchairak J, Egelhoff J, Amin R, Simakajornboon N. Sleep-related respiratory abnormalities and arousal pattern in achondroplasia during early infancy. J Pediatr. 2009 Oct;155(4):510-5.
McConnell K, Somers VK, Kimball T, Daniels S, VanDyke R, Fenchel M, Cohen A, Willging P, Shamsuzzaman A, Amin R. Baroreflex gain in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2009 Jul 1;180(1):42-8.
Lisa A. Burns, MD Pulmonologist, Pediatric and Adult Centers, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Pulmonologist, Pediatric and Adult Centers, Division of Pulmonary Medicine
Assistant Professor, UC Department of Pediatrics
Cystic fibrosis; chronic respiratory failure
MD: Loyola University, Chicago, Stritch School of Medicine, 2002.
Residency: Internal Medicine/Pediatrics, St. Louis University, St. Louis, MO.
Certification: ABP, 2006; ABIM, 2007.
Barbara Chini, MD Director, Pulmonary Fellowship Program 513-636-6771 email@example.com
Director, Pulmonary Fellowship Program
Assistant Cystic Fibrosis Center Director, Division of Pulmonary Medicine
BS: University of Notre Dame Notre Dame, IN, 1986.
MD: Vanderbilt University Medical School, Nashville, TN, 1990.
Internship: Pediatrics, University of Rochester Medical Center Pediatrics, Rochester, NY, 1991.
Residency: Pediatrics, University of Rochester Medical Center, Rochester, NY, 1993.
Fellowships: University of Rochester Medical Center, Rochester, NY, 1994; Children’s Hospital Medical Center, Cincinnati, OH, 1997.
Fricke BL, Donnelly LF, Shott SR, Kalra M, Poe SA, Chini BA, Amin RS. Comparison of lingual tonsil size as depicted on MR imaging between children with obstructive sleep apnea despite previous tonsillectomy and adenoidectomy and normal controls. Pediatr Radiol. 2006 Jun;36(6):518-23.
Shott SR, Amin R, Chini B, Heubi C, Hotze S, Akers R. Obstructive sleep apnea – Should all children with Down syndrome be tested? Arch Otolaryngol Head Neck Surg. 2006 Apr;132(4):432-436.
Mannaa M, Chini B. A case in point. A boy with shortness of breath, cough, and myalgias. J Respiratory Diseases. 2006;27(8):356-8.
Beebe DW, Wells CT, Jeffries J, Chini B, Kalra M, Amin RS. Neuropsychological Effects of Pediatric Obstructive Sleep Apnea. JINS. 2004 Nov;10(7):962-975.
Abbott MB, Donnelly LF, Dardzinski BJ, Poe SA, Chini BA, Amin RS. Obstructive Sleep Apnea: MR Imaging Volume Segmentation Analysis. Radiology. 2004 Sep;232(3):889-895.
Amin RS, Carroll J, Bean J, Jeffries J, Chini B, Bokulic R, Daniels S. Twenty Four Hour Ambulatory Blood Pressure in Children with Obstructive Sleep Apnea. Am J Respir Crit Care Med. 2004 Apr;169(8):950-56.
Donnelly LF, Shott SR, Connor RL, Chini BA, Amin RS. Causes of Persistent Obstructive Sleep Apnea Despite Previous Tonsillectomy and Adenoidectomy in Children with Down Syndrome as Depicted on Static and Dynamic Cine MRI. AJR. 2004 Jul;183(1):175-181.
John P. Clancy, MD Gunnar Esiason/Cincinnati Bell Chair 513-636-6771 firstname.lastname@example.org
Gunnar Esiason/Cincinnati Bell Chair
Research Director, Division of Pulmonary Medicine
Cystic fibrosis; airway cellular biology; CFTR regulation
John P. Clancy, MD, has served in several leadership roles at Univeristy of Alabama, Cincinnati Children's and within the international cystic fibrosis (CF) community. Some of his leadership roles include membership on the CFF Clinical Research Committee (2003 to present), the CFF-TDN Steering Committee (2002 to 2007), the CFF-TDN Translational Research Center Committee (2008 to present), DSMB membership for the Rare Lung Disease Consortium within the NIH Rare Disease Research Network (2005 to 2009, Chairman from 2010 to present); organizing committee membership for the North American CF Conference (2003 to present) and the European CF Society (2010), co-chair of the CFFT Biomarkers Consortium (2010 to present), member of the Promotion and Tenure Committee for the UAB Department of Pediatrics (2003 to 2010) and the UAB SOM (2007 to 2010, including committee chair).
Dr. Clancy has been the primary or co-mentor of more than 20 fellows, graduate students and junior faculty. He has been the initial recipient of two endowed chairs, including the Raymond K. Lyrene Chair in Pediatric Pulmonary Medicine at the University of Alabama (2005), and the Tom Boat Chair in Cystic Fibrosis Clinical and Translational Research at Cincinnati Children's (2011).
MD: University of Iowa College of Medicine, Iowa City, IA.
Residency: University of Virginia, Charlottesville, VA.
Fellowship: University of Alabama at Birmingham, Birmingham, AL.
Hug MJ, Derichs N, Bronsveld I, Clancy JP. Measurement of ion transport function in rectal biopsies. Methods Mol Biol. 2011;741:87-107.
Rowe SM, Clancy JP, Wilschanski M. Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol. 2011;741:69-86.
Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, Freedman SD, Rose LM, Mayer-Hamblett N, Dong Q, Zha J, Stone AJ, Olson ER, Ordoñez CL, Campbell PW, Ashlock MA, Ramsey BW. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010 Nov 18;363(21):1991-2003.
Clancy JP. Diagnosing cystic fibrosis in patients with non-diagnostic results: the case for intestinal current measurements. Thorax. 2010 Jul;65(7):575-6.
Rowe SM, Pyle LC, Jurkevante A, Varga K, Collawn J, Sloane PA, Woodworth B, Mazur M, Fulton J, Fan L, Li Y, Fortenberry J, Sorscher EJ, Clancy JP. DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers. Pulm Pharmacol Ther. 2010 Aug;23(4):268-78.
Com G, Clancy JP. Adenosine receptors, cystic fibrosis, and airway hydration. Handb Exp Pharmacol. 2009;(193):363-81.
Rowe SM, Clancy JP. Pharmaceuticals targeting nonsense mutations in genetic diseases: progress in development. BioDrugs. 2009;23(3):165-74.
Rowe SM, Accurso F, Clancy JP. Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials. Proc Am Thorac Soc. 2007 Aug 1;4(4):387-98. Rowe SM, Varga K, Rab A, Bebok Z, Byram K, Li Y, Sorscher EJ, Clancy JP. Restoration of W1282X CFTR activity by enhanced expression. Am J Respir Cell Mol Biol. 2007 Sep;37(3):347-56.
Carolyn M. Kercsmar, MD Co-Director, Division of Pulmonary Medicine 513-636-6771 email@example.com
Co-Director, Division of Pulmonary Medicine
Director, Asthma Center
BS: Biology, Baldwin-Wallace College, Cleveland, OH, 1972.
MD: Case Western Reserve University, Cleveland, OH, 1978.
MS: Anatomy, Case Western Reserve University, Cleveland, OH, 1978.
Kercsmar C. Exhaled nitric oxide in the diagnosis and management of childhood asthma. Ther Adv Respir Dis. 2010 Apr;4(2):71-82.
Kattan M, Kumar R, Bloomberg GR, Mitchell HE, Calatroni A, Gergen PJ, Kercsmar CM, Visness CM, Matsui EJ, Steinbach SF, Szefler SJ, Sorkness CA, Morgan WJ, Teach SJ, Gan VJ. Asthma control, adiposity, and adipokines among inner-city adolescents. J Allergy Clin Immunol. 2010 125:584-92.
Rohan J, Drotar D, McNally K, Schluchter M, Riekert K, Vavrek P, Schmidt A, Redline S, Kercsmar C. Adherence to pediatric asthma treatment in economically disadvantaged African-American children and adolescents: an application of growth curve analysis. J Pediatr Psychol. 2010 May;35(4):394-404.
Ross KR, Hart MA, Storfer-Isser A, Kibler AM, Johnson NL, Rosen CL, Kercsmar CM, Redline S. Obesity and obesity related co-morbidities in a referral population of children with asthma. Pediatr Pulmonol. 2009 Sep;44(9):877-84.
McNally KA, Rohan J, Schluchter M, Riekert KA, Vavrek P, Schmidt A, Redline S, Kercsmar C, Drotar D. Adherence to combined montelukast and fluticasone treatment in economically disadvantaged African American youth with asthma. J Asthma. 2009 Nov;46(9):921-7.
Kercsmar CM, McDowell KM. Love it or Lev it: Levalbuterol for severe acute asthma; for now, leave it. J Pediatr. 2009 155:163-64.
Short EJ, Kirchner HL, Asaad GR, Fulton S, Lewis B, Eisengart S, Baley J, Kercsmar C, Min MO, Singer LT. Long-term Sequelae of Postnatal Surfactant and Corticosteroid Therapies. BPD J Perinatol. 2008 Jul; 28(7):498-504.
Szefler SL, Mirchell H, Sorkness CA, Gergen PJ, O'Connor GT, Morgan WJ, Kattan M, Pongracic JA, Teach SJ, , Bloomberg GR, Eggleston PA, Gruchalla RS, Kercsmar CM, Liu, AH, Wildfire JJ, Busse WW. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet. 2008 372:1065-72.
Kercsmar CM. Meeting the challenges of asthma: conference summary. Respir Care. 2008 Jun;53(6):787-95.
Sobande PO, Kercsmar CM. Inhaled corticosteroids in asthma management. Respir Care. 2008 May;53(5):625-33; discussion 633-4. Review.
Gary Lewis McPhail, MD Cystic Fibrosis Center Director, Division of Pulmonary Medicine 513-636-6771 firstname.lastname@example.org
Cystic Fibrosis Center Director, Division of Pulmonary Medicine
Associate Director, Fellowship Training Program
Associate Professor, UC Department of Pediatrics
Medical education; outcomes research; quality improvement; sleep medicine; thoracic insufficiency syndrome
MD: University of Texas Southwestern Medical Center, Dallas TX, 2001.
Residency: Children's Medical Center, University of Texas Southwestern, Dallas, TX, 2004.
Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2007.
Certification: Pediatrics, 2004; Pediatric Pulmonary, 2008.
McPhail GL, Weiland J, Acton JD, Ednick M, Chima A, VanDyke R, Fenchel MC, Amin RS, Seid M. Improving evidence-based care in cystic fibrosis through quality improvement. Arch Pediatr Adolesc Med. 2010 Oct;164(10):957-60.
McPhail GL, Ednick MD, Fenchel MC, VanDyke R, Chima A, Amin RS, Seid M. Improving follow-up in hospitalised children. Qual Saf Health Care. 2010 Oct;19(5):e35
Ednick M, Cohen AP, McPhail GL, Beebe D, Simakajornboon N, Amin RS. A review of the effects of sleep during the first year of life on cognitive, psychomotor, and temperament development. Sleep. 2009 Nov 1;32(11):1449-58. Review.
McPhail GL, Acton JD, Fenchel MC, Amin RS, Seid M. Improvements in lung function outcomes in children with cystic fibrosis are associated with better nutrition, fewer chronic pseudomonas aeruginosa infections, and dornase alfa use. J Pediatr. 2008 Dec;153(6):752-7.
McPhail GL. Coagulation disorder as a presentation of cystic fibrosis. J Emerg Med. 2010 Apr;38(3):320-2.
Amin R, Somers VK, McConnell K, Willging P, Myer C, Sherman M, McPhail G, Morgenthal A, Fenchel M, Bean J, Kimball T, Daniels S. Activity-adjusted 24-hour ambulatory blood pressure and cardiac remodeling in children with sleep disordered breathing. Hypertension. 2008 Jan;51(1):84-91.
McPhail GL, Hardie WD. Cavitary lung lesions in a 2-year-old child. Respiration. 2008;76(1):117-8.
Anjaparavanda P. (AP) Naren, PhD Thomas Boat Chair in Cystic Fibrosis Research 513-803-4731 email@example.com
Thomas Boat Chair in Cystic Fibrosis Research
Co-Director, Cystic Fibrosis Research Center
Cystic fibrosis; secretory diarrhea.
Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated chloride channel located primarily on the apical surface of epithelial cells that line various organs, including the airways and the gut. CFTR dysfunction is detrimental and may result in life-threatening medical disorders. Dr. Naren's laboratory studies two such disorders; (1) Cystic fibrosis, a lethal genetic disease that affects mostly the Caucasian population (>30,000 in USA), in which the CFTR chloride channel is HYPO-functional and (2) Secretory diarrhea, a disease affecting millions of children worldwide, in which HYPER-function of the CFTR chloride channel can occur due to infectious toxins, such as cholera toxin and E. coli enterotoxin. His lab is interested in identifying interactions between CFTR and its binding partners and defining how spatiotemporal regulation of CFTR-containing macromolecular complexes in the apical compartment of polarized epithelial cells lining the secretory epithelia regulates overall fluid secretion. Our studies will identify new drug targets for cystic fibrosis, secretory diarrhea, and other diseases resulting from CFTR dysfunction and provide insights into the etiology of diseases associated with CFTR-interacting molecules.
Ren A, Zhang W, Sunitha Y, Arora K, Sinha C, Moon CS, Naren AP. MAST205 Competes with CAL for Binding to CFTR to Regulate CFTR-mediated Fluid Transport. J Biol Chem. 2013 April:26;288(17):12325-34.
Yarlagadda S, Zhang W, Penmatsa H, Ren A, Arora K, Naren AP*, Khan FA, Donnellan C, Srinivasan S, Stokes D, Kappes JC. A Young Hispanic with c.1646G>A Mutation Exhibits Severe Cystic Fibrosis Lung Disease: Is Ivacaftor an Option for Therapy? Am J Respir Crit Care Med. 2012 Oct:1 186(7):694-6. (*Corresponding Author)
Zhang W, Penmatsa H, Ren A, Punchihewa C, Lemoff A, Yan B, Fujii N, Naren AP. Functional regulation of CFTR-containing macromolecular complexes: a small-molecule inhibitor approach. Biochem J. 2011 April:15;435(2):451–62
Penmatsa H, Zhang W, Yarlagadda S, Li C, Conoley VG, Yue J, Bahouth SW, Buddington RK, Zhang G, Nelson DJ, Sonecha MD, Manganiella V, Wine JJ, Naren AP. Compartmentalized cyclic adenosine 3’,5’-monophosphate at the plasma membrane clusters PDE3A and cystic Fibrosis transmembrane conductance regulator into microdomains. Mol Biol Cell. 2010 Mar:15;21:1097-110.
Li C, Krishnamurthy PC, Penmatsa H, Marrs KL, Wang XQ, Zaccolo M, Jalink K, Li M, Nelson DJ, Schuetz JD, Naren AP. Spatiotemporal Coupling of cAMP Transporter to CFTR Chloride Channel Function in the Gut Epithelia. Cell. 2007 Nov:30;131(5): 940-51.
Li C, Dandridge KS, Di A, Marrs KL, Harris EL, Roy K, Jackson JS, Makarova NV, Fujiwara Y, Farrar, PL, Nelson DJ, Tigyi GJ, Naren AP. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions. J Exp Med. 2005 Oct:3; 202(7):975-86.
Naren AP, Cobb B, Li C, Roy K, Nelson D, Heda GD, Liao J, Kirk KL, Sorscher EJ, Hanrahan J, Clancy JP. A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin/radixin/moesin-binding phosphoprotein 50 is regulated by PKA. Proc Natl Acad Sci USA. 2003 Jan:7;100(1):342-46.
Naren AP, Anke D, Cormet-Boyaka E, Boyaka PN, McGhee JR, Zhou W, Akagawa K, Fujiwara T, Thome U, Engelhardt JF, Nelson DJ, Kirk KL. Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl(-) currents. J Clin Invest. 2000 Feb;105(3):377-86.
Naren AP, Cormet-Boyaka E, Fu J, Villain M, Blalock E, Quick MW, Kirk KL. CFTR Chloride channel regulation by an interdomain interaction. Science. 1999 Oct:15;286(5439):544-8.
Naren AP, Nelson DJ, Xie W, Jovov B, Tousson A, Pevsner J, Bennett MK, Benos DJ, Quick MW, Kirk KL. Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature. 1997 Nov:20;390(6657):302-5.
Inhibition of a cAMP transporter (MRP4) in the gut induces diarrhea. Principal Investigator. National Institutes of Health. June 2009-Apr 2018. DK080834.
LPA2-receptor containing complexes in regulating secretory diarrhea. Principal Investigator. July 2011-June 2020. RO1 (DK093045).
CF-Patient Specific Enteroids from Small Intestine and Colon. Principal Investigator. Cystic Fibrosis Foundation. July 2014-June 2016. NAREN14XXO.
Characterization of an inhibitory protein complex for cystic fibrosis therapy. Collaborator. Aug 2014-July 2019. RO1 (HL123535).
Personalizing Cystic Fibrosis Research Translation. Principal Investigator/Director-CF Human Model Systems Core. CFF-Research Development Project. July 2015-June 2019. CLANCY15R0.
Demonstrate that GC-C modulation of CFTR in the gut epithelia using enteroids from CF patients increases intestinal fluid secretion. Principal Investigator. Ironwood Grant. June 2015-May 2016. LIN-PH-44.
Michael Seid, PhD Director, Health Outcomes and Quality Care Research, Pulmonary Medicine and James M. Anderson Center for Health Systems Excellence 513-803-0083 firstname.lastname@example.org
Director, Health Outcomes and Quality Care Research, Pulmonary Medicine and James M. Anderson Center for Health Systems Excellence
Health care quality and outcomes
Visit the Seid Lab.
Michael Seid, PhD, is director of Health Outcomes and Quality of Care Research in the Division of Pulmonary Medicine and a core faculty in the James M. Anderson Center for Health Systems Excellence at Cincinnati Children's Hospital Medical Center within the UC Department of Pediatrics. Dr. Seid applies behavioral and social science to the question ‘What does it take to make sure the right treatment gets to the right child in the right way at the right time, every time?’
Dr. Seid has worked at the Center for Child Health Outcomes at Children's Hospital, San Diego and was a behavioral / research scientist at the RAND Corporation. He has been principal and co-principal investigator of several large multidisciplinary research studies, collaborates with investigators at Cincinnati Children's and beyond, and publishes widely in such journals as Medical Care, HSR: Health Services Research, Archives of Pediatrics and Adolescent Medicine, Pediatrics, American Journal of Medical Quality, the Journal of Ambulatory Pediatrics, and Milbank Quarterly.
Dr. Seid has served as the chair of Children's Hospital San Diego's Institutional Review Board, as a member of the Health Care Quality and Effectiveness Research (HCQER) Study Section at the Agency for Healthcare Quality and Research, and on several national and local expert panels. He is on the Review Board of the Journal of Clinical Outcomes Management and an ad hoc reviewer for Health Services Research, Pediatrics and the Journal of Ambulatory Pediatrics.
Grossoehme DH, Ragsdale JR, Snow A, Seid M. We were Chosen as a Family: Parents' Evolving Use of Religion when Their Child has Cystic Fibrosis. J Relig Health. 2011 Mar 16.
Muething SE, Conway PH, Kloppenborg E, Lesko A, Schoettker PJ, Seid M, Kotagal U. Identifying causes of adverse events detected by an automated trigger tool through in-depth analysis. Qual Saf Health Care. 2010 Oct;19(5):435-9.
Grossoehme DH, Ragsdale J, Cotton S, Wooldridge JL, Grimes L, Seid M. Parents' religious coping styles in the first year after their child's cystic fibrosis diagnosis. J Health Care Chaplain. 2010 Jul;16(3-4):109-22.
Grossoehme DH, Ragsdale J, Wooldridge JL, Cotton S, Seid M. We can handle this: parents' use of religion in the first year following their child's diagnosis with cystic fibrosis. J Health Care Chaplain. 2010 Jul;16(3-4):95-108.
Stevens GD, Seid M, Pickering TA, Tsai KY. National disparities in the quality of a medical home for children. Matern Child Health J. 2010 Jul;14(4):580-9.
Ernst MM, Wooldridge JL, Conway E, Dressman K, Weiland J, Tucker K, Seid M. Using Quality Improvement Science to Implement a Multidisciplinary Behavioral Intervention Targeting Pediatric Inpatient Airway Clearance. J Pediatr Psychol. 2010 Jan-Feb; 35(1):1.
Seid M, Limbers CA, Driscoll KA, Opipari-Arrigan LA, Gelhard LR, & Varni JW. Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory™ (PedsQL™) Generic Core Scales and Asthma Symptoms Scale in vulnerable children with asthma. Journal of Asthma. 2010;47:170-177.
Wirtschafter DD, Pettit J, Kurtin P, Dalsey M, Chance K, Morrow HW, Seid M, Byczkowski TL, Huber TP, Milstein JM, Bowles SM, Fichera S, Kloman S. A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. J Perinatol. 2010 Mar;30(3):170-81.
Fairbrother G, Cassedy A, Ortega-Sanchez IR, Szilagyi PG, Edwards KM, Molinari NA, Donauer S, Henderson D, Ambrose S, Kent D, Poehling K, Weinberg GA, Griffin MR, Hall CB, Finelli L, Bridges C, Staat MA; New Vaccine Surveillance Network (NVSN). High costs of influenza: Direct medical costs of influenza disease in young children. Vaccine. 2010 Jul 12;28(31):4913-9.
Christopher Siracusa, MD 513-636-6771 email@example.com
MD: American University of the Caribbean, Netherlands, Antilles, 2009.
Residency: Akron Children’s Hospital/NEOUCOM, Akron, OH, 2012.
Rhonda D. Szczesniak, PhD 513-803-0563 firstname.lastname@example.org
PhD: Statistics, University of Kentucky, Lexington, KY, 2007.
MS: Statistics, University of Kentucky, Lexington, KY, 2005.
BS: Mathematics, Radford University, Radford, VA, 2003.
Grossoehme DH, Szczesniak R, Dodd C, Opipari-Arrigan L. Dyadic Adjustment and Spiritual Activities in Parents of Children with Cystic Fibrosis. Religions. Jun 2014;5(2):385-401.
Tan CC, McDowell KM, Fenchel M, Szczesniak R, Kercsmar CM. Spirometry Use in Children Hospitalized With Asthma. Pediatr Pulmonol. May 2014;49(5):451-457.
Szczesniak RD, McPhail GL, Duan LL, Macaluso M, Amin RS, Clancy JP. A semiparametric approach to estimate rapid lung function decline in cystic fibrosis. Annals of epidemiology. Dec 2013 2013;23(12):771-777.
Clancy JP, Szczesniak RD, Ashlock MA, et al. Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function. PLoS One. Sep 2013;8(9):13.
Cudzilo CJ, Szczesniak RD, Brody AS, et al. Lymphangioleiomyomatosis Screening in Women With Tuberous Sclerosis. Chest. Aug 2013;144(2):578-585.
Pediatric Sleep Research Program. Biostatistics Mentor. K24 NIH/NHLBI. March 2011-Feb 2016.
MR predictors of infection, inflammation, and structural lung damage in CF. Biostatistician. R01 NIH. Sep 2012-June 2016.
Robert E. Wood, PhD, MD Director, Pulmonary Bronchoscopy Department 513-636-6771 email@example.com
Director, Pulmonary Bronchoscopy Department
Dr. Robert Wood, PhD, MD, is a pediatric pulmonary specialist, with particular interest in bronchoscopy. He has played a major role in the development of instrumentation and techniques for flexible bronchoscopy in pediatric patients. He is recognized as a teacher of endoscopic techniques, and has published many papers and book chapters on the subject. Additionally, he has extensive experience with clinical problems in pediatric pulmonary medicine, especially children with complex airway problems and cystic fibrosis.
Before coming to Cincinnati Children's Hospital Medical Center, Dr. Wood was on the faculty of Case Western Reserve University in Cleveland, Ohio (1976 to 1983), and the University of North Carolina at Chapel Hill (1983 to 1999).
PhD: Medical Physiology, Vanderbilt University, Nashville, TN, 1968.
MD: Vanderbilt University, Nashville, TN, 1970.
Residency: Pediatrics, Duke University Medical Center, Durham, NC, 1970 to 1972.
Fellowship: Pediatric Metabolism, National Institute of Arthritis, Metabolism, and Digestive Diseases, Bethesda, MD, 1972 to 1974; Pediatric Pulmonology, Case Western Reserve University, Cleveland, OH; Rainbow Babies and Children's Hospital, Cleveland, OH, 1974 to 1976.
Certification: Pediatrics, 1976; Pediatric Pulmonology, 1986, 1997.
Suzuki T, Sakagami T, Young LR, Carey BC, Wood RE, Luisetti M, Wert SE, Rubin BK, Kevill K, Chalk C, Whitsett JA, Stevens C, Nogee LM, Campo I, Trapnell BC. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304.
Sakagami T, Beck D, Uchida K, Suzuki T, Carey BC, Nakata K, Keller G, Wood RE, Wert SE, Ikegami M, Whitsett JA, Luisetti M, Davies S, Krischer JP, Brody A, Ryckman F, Trapnell BC. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates. Am J Respir Crit Care Med. 2010 Jul 1;182(1):49-61.
Abman S, Jobe A, Chernick V, Blaisdell C, Castro M, Ramirez MI, Gern JE, Cutting G, Redding G, Hagood JS, Whitsett J, Abman S, Raj JU, Barst R, Kato GJ, Gozal D, Haddad GG, Prabhakar NR, Gauda E, Martinez FD, Tepper R, Wood RE, Accurso F, Teague WG, Venegas J, Cole FS, Wright RJ, Gail D, Hamvas A, Kercsmar C, Kiley J, Weinmann G; NHLBI working group report. Strategic plan for pediatric respiratory diseases research: an NHLBI working group report. Pediatr Pulmonol. 2009 Jan;44(1):2-13.
Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Kosepglu ST, Link B, Martin RA, Molter DW, MuAoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E. Multidisciplinary Management of Hunter Syndrome. Pediatrics. 2009; 124:e1228-39.
Suzuki T, Sakagami T, Rubin BK, Nogee LM, Wood RE, Zimmerman SL, Smolarek T, Dishop MK, Wert SE, Whitsett JA, Grabowski G, Carey BC, Stevens C, van der Loo JC, Trapnell BC. Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA. J Exp Med. 2008 Nov 24;205(12):2703-10.
Wood RE. Evaluation of the upper airway in children. Curr Opin Pediatr. 2008 Jun;20(3):266-71. Review.
Boesch RP, Daines C, Willging JP, Kaul A, Cohen AP, Wood RE, Amin RS. Advances in the diagnosis and management of chronic pulmonary aspiration in children. Eur Respir J. 2006 Oct;28(4):847-61. Review.
Zur KB, Wood RE, Elluru RG. Pediatric postcricoid vascular malformation: a diagnostic and treatment challenge. Int J Pediatr Otorhinolaryngol. 2005 Dec;69(12):1697-701.
Lim LH, Cotton RT, Azizkhan RG, Wood RE, Cohen AP, Rutter MJ. Complications of metallic stents in the pediatric airway. Otolaryngol Head Neck Surg. 2004 Oct;131(4):355-61.
Wood RE. The emerging role of flexible bronchoscopy in pediatrics. Clin Chest Med. 2001 Jun;22(2):311-7, viii. Review.
Jason C. Woods, PhD Director, Center for Pulmonary Imaging Research 513-803-4463 firstname.lastname@example.org
Director, Center for Pulmonary Imaging Research
Hyperpolarized gas; pulmonary MRI; translational studies; image-guided pulmonary interventions
Dr. Woods is one of the world’s experts on hyperpolarized-gas MRI and the use of such gas MRI to measure regional lung function, microstructure and physiology. He began his career in physics, radiology, and the dean's office at Washington University in St Louis, and moved to Cincinnati Children's in 2013 to apply new imaging techniques to pediatric translational research. He leads multiple team projects related to the multidisciplinary study of lung structure, function, biology and physiology. In particular, imaging applications to the study of cystic fibrosis, BPD, rare-lung diseases, and allograft rejection are all active areas of current research.
Dr. Woods directs the Center for Pulmonary Imaging Research at Cincinnati Children’s Hospital Medical Center. The center is a multidisciplinary research and training program at the intersection of pulmonary medicine, radiology, and neonatology.
PhD: Washington University, St. Louis, MO, 2002.
Postdoctoral: Washington University, St. Louis, MO, 2004.
Walkup LL, Tkach JA, Higano NS, Thomen RP, Fain SB, Merhar SL, Fleck RJ, Amin RS, Woods JC. Quantitative magnetic resonance imaging of bronchopulmonary dysplasia in the NICU environment. Am J Respir Crit Care Med. 2015 Jul 17.
Walkup LL, Woods JC. Newer Imaging techniques for BPD. Clinics in Perinatology. 2015.
Young SM, Liu S, Rashika J, Batie M, Kofron M, Guo J, Woods JC, Varisco B. Localization and stretch-dependence of elastin remodeling in lung development and compensatory regrowth. J Appl Physiol. 2015;118:921-931.
Li Y, Wang H, Tkach J, Roach D, Woods J, Dumoulin C. Wavelet-space Correlation Imaging for High-speed MRI without Motion Monitoring or Data Segmentation. Magn Reson Med. 2015.
Guo J, Huang HJ, Wang X, Wang W, Ellison H, Thomen RP, Gelman AE, Woods JC. Imaging mouse lung allograft rejection with 1H MRI. Magn Reson Med. 2015;274:250-9.
Thomen RP, Sheshadri A, Quirk JD, Kozlowski J, Ellison HD, Castro M, Woods JC. Regional ventilation changes in severe asthma after bronchial thermoplasty by 3He MRI and CT. Radiology. 2015;573:1970-8.
Walkup L, Woods JC. Translational Applications of Hyperpolarized 3He and 129Xe. NMR Biomed. 2014;27:1429-38.
Pennati F, Salito C, Baroni G, Woods JC, Aliverti A. Comparison Between Multivolume CT-Based Surrogates of Regional Ventilation in Healthy Subjects. Acad Rad. 2014;21:1268-75.
Pennati F, Quirk JD, Yablonskiy DA, Castro M, Aliverti A, Woods JC. Assessment of regional lung function by multi-volume 1H-MRI in health and obstructive lung disease: comparison with 3He-MRI. Radiology. 2014;273:580-90.
Phillipot Q, Deslée G, Adair-Kirk T, Woods JC, Byers D, Dury S, Perotin Collard J-M, Lebargy F, Cassan C, Le Naour R, Holtzman MJ, Pierce RA. Increased iron sequestration in alveolar macrophages in chronic obstructive pulmonary disease. Plos One. 2014;9:e96285.
Salito C, Barazzetti L, Woods J, Aliverti A. Heterogeneity of Specific Gas Volume Changes: a New Tool to Plan Lung Volume Reduction in Emphysema. Chest. 2014;146:1554-65.
Chang YV, Quirk JD, Ruset IC, Atkinson JJ, Hersman FW, Woods JC. Quantification of human lung structure and physiology using hyperpolarized 129Xe. Magn Reson Med. 2014;71:339-344.
Nanhua Zhang, PhD 513-803-9108 email@example.com
Missing data; comparative effectiveness; clinical trial design; meta-analysis; scale development; joint modeling; environmental health; community-based intervention; health disparity; behavioral intervention; health psychology
Dr. Zhang earned his PhD in biostatistics from the University of Michigan in Ann Arbor. Prior to joining Cincinnati Children’s Hospital Medical Center, he was a faculty member at the University of South Florida in Tampa. His statistical methodology research has covered missing data, causal inference, clinical trial design, joint modeling and meta-analysis. His applied research interests include environmental health, community-based intervention, health disparity, behavioral intervention and health psychology. His research “early childhood lead exposure on academic achievement” received media coverage on TV, radio, newspapers, magazines, and various online media such as Time.com and Yahoo.com.
Dr. Zhang has authored 20 published papers and made numerous presentations at national and international conferences. He has served as a reviewer for 15 different journals including: Biometrika, Statistics in Medicine, Statistics Sinica, Annals of Applied Statistics, American Journal of Public Health, Annals of Epidemiology, Health Education Research. He has taught graduate and advanced doctoral courses in linear models, survival analysis and statistical computing.
BS: Shanghai University of Finance and Economics, Shanghai, China.
MS: Bowling Green State University, Bowling Green, OH.
PhD: University of Michigan, Ann Arbor, MI.
Zhang N, Little RJA. Subsample ignorable likelihood for accelerated failure time models with missing predictors. Lifetime Data Anal. 2014 Aug 5.
Huang Y, Xing D, Zhang N, Chen H. Jointly Modeling Event Time and Skewed-Longitudinal Data with Missing Response and Mismeasured Covariate. J Biopharm Stat. 2014 Jun 6.
Zhang N, Chen H, Zou Y. A joint model of binary and longitudinal data with non-ignorable missingness, with application to marital stress and late life depression. J Applied Statistics. 2014;41(5);1028-39.
Brannick MT, Zhang N. Bayesian Meta-analysis of Coefficient Alpha. Res Synthesis Methods. 2013;4(2):198-207.
Chen H, Zhang N, Lu X, Chen S. Caution regarding the choice of standard deviations to guide sample size calculations in clinical trials. Clin Trials. 2013 Aug;10(4)522-9.
Zhang N, Baker HW, Tufts M, Raymond RE, Salihu H, Elliott MR. Early childhood lead exposure and academic achievement: evidence from Detroit Public Schools (2008-2010). Am J Public Health. 2013 Mar;103(3):e72-7.
Zhang N, Little RJA. A pseudo-Bayesian approach to regression with missing covariates. Biometrics. 2012 Sep;68(3):933-42.
Little RJA, Zhang N. Subsample ignorable likelihood for regression with missing data. J R Stat Soc Ser C Appl Stat. 2011;60, 591-605.
Resnicow K, Zhang N, Vaughan R, Reddy SP, James S, Murry DM. When intraclass correlation coefficients go awry: a case study from a school-based smoking prevention study in South Africa. Am J Public Health. 2010 Sep;100(9):1714-48.
Resnicow K, Davis RE, Zhang N, Strecher VJ, Tolsma D, Calvi J, Alexander G, Anderson JP, Wiese C. Tailoring a fruit and vegetable intervention on ethnic identity: results of a randomized study. Health Psychol. 2009 Jul;28(4):394–403.
Assem G. Ziady, PhD Director, The Cystic Fibrosis Biomarker Analysis and Assay Development RDP Core 513-803-9094 firstname.lastname@example.org
Director, The Cystic Fibrosis Biomarker Analysis and Assay Development RDP Core
Associate Professor, Case Western Reserve University
Dr. Ziady received his undergraduate education at Boston College in biochemistry in 1993. He completed his graduate studies on cell physiology and received his PhD degree in 1999 from Case Western Reserve University. Following his postdoctoral training at the Department of Pediatrics at Case Western Reserve University, he began a year-long externship at the Cleveland Clinic Proteomic facility in early 2002. In 2003, Dr. Ziady joined the faculty at the Case Western Reserve University Department of Pediatrics as assistant professor. In 2011, Dr. Ziady joined the faculty at the Emory University Department of Pediatrics as an associate professor and served as the associate director of Cystic Fibrosis Basic & Translational Research at Emory University.
In 2014, Dr. Ziady was recruited by the CF program at Cincinnati Children’s Hospital Medical Center, where he joined the faculty as associate professor of pediatrics within the UC College of Medicine in November. Dr. Ziady’s research has been supported by the State of Ohio, the Cystic Fibrosis Foundation, and the National Institutes of Health. His laboratory focuses on the differential regulation of Nrf2 signaling pathways in the inflammatory lung disease observed cystic fibrosis. Dr. Ziady's lab also has unique expertise in developing and characterizing DNA nanoparticles for nonviral gene delivery to the lung, liver, and brain. Finally, Dr. Ziady’s lab has expertise in proteomic analyses for biomarker discovery and the examination of systems biology of various tissues. He is an inventor on five patents (2 USA, 2 EU, and 1 international) pertaining to DNA nanoparticles, and one provisional patent pertaining to modulation of inflammatory signaling. In the past 15 years, he has authored 33 manuscripts and book chapters, has an h-index of 19, and has been invited to present 42 talks on his work at national and international conferences and institutions.
BS: Biochemistry, Boston College, Boston, MA, 1993.
PhD: Cell Physiology, Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, 1999.
Postdoctoral Fellowship: Non-viral gene transfer, Pediatrics, Case Western Reserve University, Cleveland, OH, 2002.
Externship: Proteomic analysis of redox mediated inflammation in CF, Cell Biology, Cleveland Clinic Foundation, Cleveland, OH, 2003.
Ziady AG, Hansen J. Redox balance in Cystic Fibrosis. Int J Biochem Cell Biol. 2014 Jul;52:113-23.
Cheng Y, Doane TL, Chuang CH, Ziady A, Burda C. Near infrared light-triggered drug generation and release from gold nanoparticle carriers for photodynamic therapy. Small. 2014;10(9):1799-1804. (Joint corresponding author with C. Burda).
Ziady AG, Sokolow A, Shank S, Corey D, Myers R, Plafker S, Kelley TJ. Interaction with CREB binding protein modulates the activities of Nrf2 and NF-κB in Cystic Fibrosis Airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2012;302(11):L1221-1231.
Yurek DM, Fletcher AM, McShane M, Kowalczyk TH, Padegimas L, Weatherspoon MR, Kaytor MD, Cooper MJ, Ziady AG. DNA Nanoparticles: Detection of long-term transgene activity in brain using bioluminescence imaging. Mol Imaging. 2011;10(5):327-339.
Lancioni CL, Li Q, Thomas JJ, Ding X, Thiel B, Drage MG, Pecora ND, Ziady AG, Shank S, Harding CV, Boom WH, Rojas RE. Mycobacterium tuberculosis lipoproteins induce human memory CD4+ T cell activation via toll-like receptors 1 and 2. Infect and Immun. 2011;79(2):663-673.
Chen X, Shank S, Davis PB, Ziady AG. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid. Molec Ther. 2011;19(1):93-102.
Ziady AG, Kotlarchyk M, Bryant L, McShane M, Lee Z. Bioluminescent imaging of reporter gene expression in the lungs of wildtype and model mice following the administration of PEG-stabilized DNA nanoparticles. Microsc Res Tech. 2010;73(9):918-928.
Nichols DP, Ziady AG, Shank SL, Eastman JF, Davis PB. The Triterpenoid CDDO limits inflammation in preclinical models of Cystic Fibrosis lung disease. Am J Physiol Lung Cell Mol Physiol. 2009;297(5):L828-836.
Yurek DM, Fletcher AM, Smith GM, Seroogy KB, Ziady AG, Molter J, Kowalczyk TH, Padegimas L, Cooper MJ. Long-term transgene expression in the Central Nervous System using DNA nanoparticles. Mol Ther. 2009;17(4):641-650.
Chen J, Kinter M, Shank S, Cotton C, Kelley TJ, Ziady AG. Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production. PLoS ONE. 2008;3(10):e3367.
Nrf2 dysfunction in CF epithelia. Principal Investigator. National Institutes of Health/National Heart, Lung, and Blood Institute. Jul 2011-Jun 2016. 5R01HL109362.
MR predictors of infection, inflammation, and structural damage in CF. Contract Principal Investigator. National Institutes of Health/National Heart, Lung, and Blood Institute. Sep 2012-Jun 2017. 1R01HL116226.
CFF Cincinnati Children's Hospital Medical Center Research Development Program. Core Director. Cystic Fibrosis Foundation. Jul 2015-Jun 2019.
Gilead Sciences Research Grant. Contract Principal Investigator. Gilead Sciences. Jul 2014-Jun 2016.
Amanda F. Dressman, MSN, APRN, PNP-BC Cystic Fibrosis Nurse Practitioner, Division of Pulmonary Medicine 513-636-6771 email@example.com
Cystic Fibrosis Nurse Practitioner, Division of Pulmonary Medicine
Amanda Dressman started her nursing career as an ADN in 2001 at Cincinnati Children's. Amanda has since continued her education to obtain both a BSN, and most recently her MSN, PNP. Amanda has practiced in the role of a floor nurse, patient care facilitator, and clinical manager on the adolescent/cystic fibrosis unit.
PNP: Northern Kentucky University, Highland Heights, KY, 2009.
Certification: Pediatric Nurse Practitioner, 2009.
Stephanie Spear Filigno, PhD Pediatric Psychologist, Clinical, Behavioral Medicine & Clinical Psychology 513-636-4336 firstname.lastname@example.org
Pediatric Psychologist, Clinical, Behavioral Medicine & Clinical Psychology
Behavior management in toddlers and preschoolers; adherence to treatment in chronic illness (CF and obesity); coping and adjustment; child anxiety; toileting
Stephanie Spear Filigno, PhD, joined Behavioral Medicine and Clinical Psychology as an assistant professor within the UC Department of Pediatrics after completing her research fellowship at Cincinnati Children’s under the mentorship of Drs. Scott Powers and Lori Stark.
During her fellowship she developed and delivered family-based behavior and nutrition treatments for obese preschoolers and young children with cystic fibrosis. She continues to collaborate on these projects, and independently develop quality improvement projects in cystic fibrosis with an early intervention behavior and nutrition focus.
Stephanie also works with the Cystic Fibrosis Center to help families cope with the demands of the cystic fibrosis treatment regimen, reach nutrition recommendations, and improve adherence to treatment.
PhD: University of Nevada, Reno, NV, 2007.
Internship: Boystown, Nebraska Internship Consortium of Professional Psychology, Omaha, NE, 2006-2007.
Fellowship: Pediatric Psychology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2007-2009.
Stark LJ, Spear S, Boles R, Kuhl E, Ratcliff M, Scharf C, Bolling C, Rausch J. A pilot randomized controlled trial of a clinic and home-based behavioral intervention to decrease obesity in preschoolers. Obesity (Silver Spring). 2011 Jan;19(1):134-41.
Borowitz B, Robinson K, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. Journal of Pediatrics. 2009;155(6):S73-S93.
Karla E. Foster, MS
Exercise Physiologist, Division of Pulmonary Medicine 513-636-6771 email@example.com
Daniel H. Grossoehme Chaplain, Division of Pulmonary Medicine 513-636-0848 firstname.lastname@example.org
Chaplain, Division of Pulmonary Medicine
Doctor of Ministry: (Pastoral Counseling), Louisville Presbyterian Theological Seminary, 2006.
MDiv: Protestant Episcopal Theological Seminary in Virginia, Alexandria, VA, 1992.
BS: Astrophysics, Indiana University, 1985.
Grossoehme DH, Opipari-Arrigan L, VanDyke R, Thurmond S, Seid M. Relationship of adherence determinants and parental spirituality in cystic fibrosis. Pediatr Pulmonol. 2012 Jun;47(6):558-66.
Grossoehme DH, Jacobson CJ, Cotton S, Ragsdale J, VanDyke R, Seid M. Written prayers and religious coping in a paediatric hospital setting. Mental Health, Religion & Culture. 2011 14(5): 423-432.
Grossoehme DH, Ragsdale JR, Snow A, Seid M. We were chosen as a family: Parents’ evolving use of religion when their child has cystic fibrosis. J Relig Health. 2012 Dec;51(4):1347-58.
Cotton S, Grossoehme DH, McGrady M. Religious coping and use of prayer in sickle cell disease. Pediatric Blood Cancer. 2012 Feb;58(2):244-9.
Grossoehme DH, VanDyke R, Jacobson CJ, Cotton S, Ragsdale J, Seid M. Written prayers in a pediatric hospital: linguistic analysis. Psychology of Religion & Spirituality. 2010 2(4): 227-233.
Grossoehme DH, Ragsdale JR, Wooldridge JL, Cotton S, Grimes L, Seid M. Parents’ use of religious coping in the first year after their child’s chronic illness diagnosis. Journal of Health Care Chaplaincy. 2010 16(3): 109-122.
Grossoehme DH, Ragsdale J, Wooldridge JL, Cotton S, Seid M. We can handle this: Parents’ use of religion in the first year following their child’s diagnosis with cystic fibrosis. Journal of Health Care Chaplaincy. 2010 16(3): 95-108.
Grossoehme DH, VanDyke R, Seid M. Spirituality’s role in chronic disease self-management: Sanctification of the body in families dealing with cystic fibrosis. Journal of Health Care Chaplaincy. 2009 15, 1-10.
Cotton S, Grossoehme D, Rosenthal SL, McGrady ME, Roberts YH, Hines J, Yi MS, Tsevat J. Religious/spiritual coping in adolescents with sickle cell disease: A pilot study. Journal of Pediatric Hematology/Oncology. 2009 31(5), 313-318.
Grossoehme DH, Ragsdale J, Dixon C, Berz K, Zimmer M. The changing face of medical education: the role of religion, integrative medicine and osteopathy. The Open Medical Education Journal. 2009 2, 1-8.
Kathy Santoro, RD
Cystic Fibrosis Dietitian, Division of Pulmonary Medicine 513-636-6771 email@example.com
Jackie Taylor, RD
Cystic Fibrosis Dietitian, Division of Nutrition Therapy 513-636-6771 firstname.lastname@example.org
Jeanne Weiland, MSN, APRN, PNP Cystic Fibrosis Nurse Practitioner, Division of Pulmonary Medicine 513-636-7438 email@example.com
MSN: Master of Science in Nursing, Specialization in Pediatric and Adolescent Psychiatric Nursing, University of Cincinnati, Cincinnati, Ohio, 1986.
BSN: Bachelor of Science in Nursing, Georgetown University Nursing School, Washington, D.C., 1979.
Ernst MM, Wooldridge JL, Conway E, Dressman K, Weiland J, Tucker K, Seid M. Using quality improvement science to implement a multidisciplinary behavioral intervention targeting pediatric inpatient airway clearance. J Pediatr Psychol. 2010 Jan-Feb;35(1):14-24.
Sobande PO, Acton JD, Amin RS, Weiland J. Obliterative bronchiolitis in a 13-year-old pre-transplant cystic fibrosis patient. J Cyst Fibros. 2008 Jan;7(1):92-4.
Britto MT, Schoettker PJ, Pandzik GM, Weiland J, Mandel KE. Improving influenza immunisation for high-risk children and adolescents. Qual Saf Health Care. 2007 Oct;16(5):363-8.
Weiland J, Schoettker PJ, Byczkowski T, Britto MT, Pandzik G, Kotagal UR. Individualized daily schedules for hospitalized adolescents with cystic fibrosis. J Pediatr Health Care. 2003 Nov-Dec;17(6):284-9.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center. All rights reserved.